Skye Bioscience, Inc. (SKYE)
0.7337
+0.01
(+1.76%)
USD |
NASDAQ |
Feb 13, 16:00
0.7337
0.00 (0.00%)
After-Hours: 16:10
Skye Bioscience Cash from Investing (Quarterly) : 7.967M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| Eli Lilly & Co. | -- |
| Theravance Biopharma, Inc. | -100.25M |
| Viking Therapeutics, Inc. | 75.61M |
| Kyntra Bio, Inc. | 87.16M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.36M |
| Free Cash Flow | -41.53M |
| Free Cash Flow Per Share (Quarterly) | -0.3369 |
| Free Cash Flow to Equity (Quarterly) | -13.32M |
| Free Cash Flow to Firm (Quarterly) | -13.36M |
| Free Cash Flow Yield | -142.4% |